Baltimore city hub: 9 funds and 5 startups matched from our directory. Johns Hopkins health/cyber and applied research commercialization.

MD · Northeast

Baltimore venture capital & startups

Baltimore Hopkins clinical AI, diagnostics, and medtech — TEDCO, Latimer, TCP, kweliTV, Bayesian Health, Pearl, Inner Logic, Neurava.

Baltimore now has four local /fund/ profiles (TEDCO, Maryland Momentum Fund, Latimer Ventures, TCP Venture Capital) plus five curated startups: kweliTV, Bayesian Health, Pearl Diagnostics, Inner Logic, and Neurava — Hopkins commercialization with honest national syndicate depth on larger rounds.

Funds matched

9

Startups matched

5

Wave

Expand

Browse

All funds

Baltimore city/metro HQ aliases only. Do not treat DC/Arlington fund HQs as Baltimore.

Venture firms in Baltimore

Matched from fund headquarters in our directory (alias-based). Dual-HQ firms may appear in more than one city.

Startups we cover in Baltimore

Matched from startup hq fields. Many profiles still lack HQ — curated lists in editorial notes fill gaps when verified.

Coverage gaps

  • Baltimore Angels / Dingman Center Angels

    Common first-check networks — not ingested as directory funds

  • Catalio Capital Management

    Hopkins-adjacent biotech deals (e.g. Bayesian syndicates) — no /fund/ page yet

  • Under Armour / Connected Fitness successors

    Historic Baltimore consumer employer signal — not a current startup profile

  • NextStep Robotics

    Baltimore medical device with recent SEC filings — pending verified /startup/ profile

Related reading

Baltimore FAQs

Practical answers for founders researching this investor.

Local profiles: TEDCO, Maryland Momentum Fund, Latimer Ventures, and TCP Venture Capital. National health firms on covered companies include a16z, Define, F-Prime, and General Catalyst. See /vc/baltimore.
kweliTV, Bayesian Health, Pearl Diagnostics, Inner Logic, and Neurava — browse /vc/baltimore.
Pair Maryland seed (TEDCO, Latimer, TCP) with Hopkins clinical proof, then pitch national digital-health or device specialists for Series A+.
Seed and state programs are strongest locally; growth checks on clinical AI and medtech usually come from national multi-stage firms once evidence is clear.